These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23808102)

  • 41. Health related claims, the market for information, and the first amendment.
    Beales JH
    Health Matrix Clevel; 2011; 21(1):7-30. PubMed ID: 21847896
    [No Abstract]   [Full Text] [Related]  

  • 42. The Supreme Court's influence on medicine and health: the Rehnquist Court, 1986-2005.
    Gostin LO
    JAMA; 2005 Oct; 294(13):1685-7. PubMed ID: 16204668
    [No Abstract]   [Full Text] [Related]  

  • 43. [What Is Involved in the Training Program for a Japanese Academic Detailer?].
    Komoda M; Negishi K; Mano Y; Ozeki R; Goto K
    Yakugaku Zasshi; 2019; 139(8):1107-1110. PubMed ID: 31366847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Doctors and detailers: therapeutic education or pharmaceutical promotion?
    Lexchin J
    Int J Health Serv; 1989; 19(4):663-79. PubMed ID: 2583883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Legal features of the drug advertising.
    Pashkov VM; Olefir AA; Bytyak OY
    Wiad Lek; 2017; 70(1):133-138. PubMed ID: 28343208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug product advertising and prescribing: a review of the evidence.
    Smith MC
    Am J Hosp Pharm; 1977 Nov; 34(11):1208-24. PubMed ID: 412419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Office of the Future Project: the integration of new technology into office practice. Academic detailing through the super highway. Quebec Research Group on Medication Use in the Elderly.
    Tamblyn RM; Jacques A; Laprise R; Huang A; Perreault R
    Clin Perform Qual Health Care; 1997; 5(2):104-8. PubMed ID: 10167210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Supreme Court's decision to recognize a psychotherapist privilege in Jaffee v. Redmond, 116 S. Ct. 1923 (1996): the meaning of "experience and the role of "reason" under Federal Rule of Evidence 501.
    Amann DM; Imwinkelried EJ
    Univ Cincinnati Law Rev; 1997; 65(4):1019-49. PubMed ID: 16086528
    [No Abstract]   [Full Text] [Related]  

  • 49. No data-mining zone. Appeals court ruling favors N.H. law.
    Conn J
    Mod Healthc; 2008 Nov; 38(47):17. PubMed ID: 19058432
    [No Abstract]   [Full Text] [Related]  

  • 50. For sale: physicians' prescribing data.
    Steinbrook R
    N Engl J Med; 2006 Jun; 354(26):2745-7. PubMed ID: 16807410
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmaceutical company influences on medication prescribing and their potential impact on quality use of medicines.
    Kyle GJ; Nissen LM; Tett SE
    J Clin Pharm Ther; 2008 Oct; 33(5):553-9. PubMed ID: 18834371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correction to "Empirical support for the United States Supreme Court's protection of the psychotherapist-patient privilege".
    Marsh JE
    Ethics Behav; 2004; 14(2):197-9. PubMed ID: 15835047
    [No Abstract]   [Full Text] [Related]  

  • 53. The US Opioid Crisis: Current Federal and State Legal Issues.
    Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK
    Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pitfalls of deducing ethics from behavioral economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing.
    Huddle TS
    Am J Bioeth; 2010 Jan; 10(1):1-8. PubMed ID: 20077321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of Wyeth v. Levine on FDA regulation of prescription drugs.
    Ausness RC
    Food Drug Law J; 2010; 65(2):247-83, i-ii. PubMed ID: 24475542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Better the devil you know than the doctor you don't: is advertising drugs to doctors more harmful than advertising to patients?
    Vaithianathan R
    J Health Serv Res Policy; 2006 Oct; 11(4):235-9. PubMed ID: 17018198
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers.
    Findlay SD
    Pharmacoeconomics; 2001; 19(2):109-19. PubMed ID: 11284378
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prescribing habits of Peruvian physicians and factors influencing them.
    Zárate Cárdenas E; Liosa Isenrich L
    Bull Pan Am Health Organ; 1995 Dec; 29(4):328-37. PubMed ID: 8605524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Direct to consumer advertising in pharmaceutical markets.
    Brekke KR; Kuhn M
    J Health Econ; 2006 Jan; 25(1):102-30. PubMed ID: 16280182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmaceutical Research and Manufacturers of America v. Walsh: the Supreme Court allows the states to proceed with expanding access to drugs.
    Jost TS
    Yale J Health Policy Law Ethics; 2004; 4(1):69-84. PubMed ID: 15052860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.